Search Results - "Nixon, I"

From Singles Leaders to Leadership as a Social Process: Introducing Distributed Leadership in Health and Care by Nixon, I., Lindsay, C.

Get full text

Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection by Nixon, I. J., Wang, L. Y., Ganly, I., Patel, S. G., Morris, L. G., Migliacci, J. C., Tuttle, R. M., Shah, J. P., Shaha, A. R.

“…Background The role of prophylactic central neck dissection (CND) in the management of papillary thyroid cancer (PTC) is controversial. This report describes…”
Get full text

Pathologic complete response in patients with localized soft tissue sarcoma treated with neoadjuvant therapy and its correlation with clinical outcomes: A systematic review by Boulouta, A., Kyriazoglou, A., Kotsantis, I., Economopoulou, P., Anastasiou, M., Pantazopoulos, A., Kyrkasiadou, M., Moutafi, M., Gavrielatou, N., Zazas, E., Caglar, C., Nixon, I., Tolia, M., Kavourakis, G., Psyrri, A.

“…•The choice of perioperative treatment for soft tissue sarcomas (STS) remains a challenging decision.•There is a shift towards neoadjuvant therapy due to…”
Get full text

Introducing ethanol ablation as a treatment for thyroid cysts in the emergency setting by Robb, L, Hey, S Y, Reid, H, Nixon, I J

“…Ethanol ablation for the treatment of thyroid cysts has been well documented in the literature as a safe, effective treatment option in the elective setting…”
Get more information

The use of Transnasal Humidified Rapid‐Insufflation Ventilatory Exchange in 17 cases of subglottic stenosis by To, K., Harding, F., Scott, M., Milligan, P., Nixon, I.J., Adamson, R., McNarry, A.F.

Get full text

Transnasal humidified rapid-insufflation ventilatory exchange ('THRIVE') in the coronavirus disease 2019 pandemic by Hey, S Y, Milligan, P, Adamson, R M, Nixon, I J, McNarry, A F

“…Since the start of the coronavirus disease 2019 pandemic, transnasal humidified rapid-insufflation ventilatory exchange ('THRIVE') has been classified as a…”
Get more information

Outcomes in Patients With Poorly Differentiated Thyroid Carcinoma by Ibrahimpasic, T, Ghossein, R, Carlson, D. L, Nixon, I, Palmer, F. L, Shaha, A. R, Patel, S. G, Tuttle, R. M, Shah, J. P, Ganly, I

“…Background: Poorly differentiated thyroid cancer (PDTC) accounts for only 1–15% of all thyroid cancers. Our objective is to report outcomes in a large series…”
Get full text

The utility of parathyroid autofluorescence as an adjunct in thyroid and parathyroid surgery 2023 by Pace‐Asciak, P., Russell, J., Solorzano, C., Berber, E., Singer, M., Shaha, A. R., Khafif, A., Angelos, P., Nixon, I., Tufano, R. P.

“…Abstract Thyroid and parathyroid surgery requires careful dissection around the vascular pedicle of the parathyroid glands to avoid excessive manipulation of…”
Get full text

Best practice in reducing the suicide risk in head and neck cancer patients: a structured review by Twigg, J.A., Anderson, J.M., Humphris, G., Nixon, I., Rogers, S.N., Kanatas, A.

“…The treatment of head and neck cancer (HNC) is often radical and the patient’s journey challenging, especially for individuals who are struggling with…”
Get full text

A quantitative assessment of the number of disease foci in papillary thyroid cancer by Evans Harding, N., Simo, Richard, Li, L., Maniam, P., Adamson, R., Hay, A., Conn, B., Lyall, M., Nixon, I.J.

“…Multifocality is a frequent feature of papillary thyroid carcinoma (PTC). Its prognostic value is controversial although national guidelines recommend…”
Get full text

Neoadjuvant tyrosine kinase inhibitor therapy in locally advanced differentiated thyroid cancer: a single centre case series by Yeo, J J Y, Stewart, K, Maniam, P, Arman, S, Srinivasan, D, Wall, L, MacNeill, M, Strachan, M, Nixon, I

“…Primary surgical resection remains the mainstay of management in locally advanced differentiated thyroid cancer. Tyrosine kinase inhibitors have recently shown…”
Get more information

Surgical management of primary thyroid tumours by Asimakopoulos, Panagiotis, Nixon, Iain J

“…Abstract The majority of patients who present with well differentiated thyroid cancer will require surgery, but decisions on the appropriate primary procedure…”
Get full text

The impact of completion thyroidectomy by Sawant, R., Hulse, K., Sohrabi, S., Yeo, J.C.L., Pal, K., Gibb, F.W., Adamson, R., Nixon, I.J.

“…The oncological benefit of completion thyroidectomy (CT) following thyroid lobectomy (TL) is presumed to be similar to that of upfront total thyroidectomy(TT),…”
Get full text

Primary care triaging of head and neck cancer referrals using the head and neck cancer risk calculator version 2: impact on a tertiary head and neck service by Li, L, Tikka, T, Morton, C, Chan, C, Hayois, L, Henderson, M, Hastie, C, Lee, L, Porteus, L, Nixon, I

“…This study aimed to investigate the use of the head and neck cancer risk calculator version 2 in a primary care setting and to evaluate the impact of the risk…”
Get more information

The role of radioactive iodine in the management of patients with differentiated thyroid cancer – An oncologic surgical perspective by Nixon, I.J., Shah, J.P., Zafereo, M., Simo, R.S., Hay, I.D., Suárez, C., Zbären, P., Rinaldo, A., Sanabria, A., Silver, C., Mäkitie, A., Vander Poorten, V., Kowalski, L.P., Shaha, A.R., Randolph, G.W., Ferlito, A.

“…With improved understanding of the biology of differentiated thyroid carcinoma its management is evolving. The approach to surgery for the primary tumour and…”
Get full text

Does Frequent Follow-up After Radical Treatment of Oropharyngeal Cancer Improve Outcomes? by Sundaramurthy, A, MacLennan, K.L, Fragkandrea-Nixon, I

Get full text

Re: More evidences are needed in reducing the suicide risk in head and neck cancer patients by Twigg, J.A., Anderson, J.M., Humphris, G., Nixon, I., Rogers, S.N., Kanatas, A.

Get full text

Complications and predisposing factors from a decade of total laryngectomy by Thompson, C S G, Asimakopoulos, P, Evans, A, Vernham, G, Hay, A J, Nixon, I J

“…Total laryngectomy is often utilised to manage squamous cell carcinoma of the larynx or hypopharynx. This study reports on surgical trends and outcomes over a…”
Get more information

Practice patterns in management of differentiated thyroid cancer since the 2014 British Thyroid Association (BTA) guidelines by Maniam, P, Hey, S Y, Evans-Harding, N, Li, L, Conn, B, Adamson, R M, Hay, A J, Lyall, M, Nixon, I J

“…The updated 2014 BTA guidelines emphasised a more conservative, risk adapted model for the management of low-risk differentiated thyroid cancer (DTC). In…”
Get full text

Refining definitions within low‐risk differentiated thyroid cancers by Nixon, I.J., Simo, R.S., Kim, D.

Get full text